Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
Go back to Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study| (NASDAQ: LEXX) | Delayed: 4.07 +0.04 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.03 | 52 Week High | $ | |||
| Open | $4.01 | 52 Week Low | $ | |||
| Day High | $4.30 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $ | |||
| Volume | 32,368 | |||||
| (NASDAQ: LEXXW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 50,657 | |||||



